Teams at Tianjin University and the University of Theta Science and Technology have developed a “MetaBOC” in China to develop a brain-on-a-chip. It is an interface that humans cannot use. MetaBOC is now open source, a platform designed for use by biocomputers in practical applications.
Extracted from organic matter, connected to electronic chips, they demonstrate very high learning rates. For this reason, they are referred to as part of their names, for example, I, and most importantly, these living systems can improve, changing their structure for different tasks.
Disadvantages of two biocomputers. Firstly, it is living tissue, very delicate for others. No need to adjust, heat, antiviral, stimulate. First use the biocomputer on the tractor and remove it, all-terrain work is too risky. Secondly, it is very difficult to exchange information with a s s s s s s s s s s s s and brain taani no sovey This is exactly the problem that Chinese scientists are solving.

No unusual intelligence can be found in the meaning of intelligence, by analyzing the signals that the organisms emit. MetaBOC provides information between them. As an example of their minds, the Chinese scientific phenomena, as can be found locally, recognize and bypass obstacles.
Who is the leading director of Cortical Labs Brett Kagan, I am engaged in tax developments, these questions in the second case are also not worth attention. Brain tissue is alive, but it is not a full-fledged Being, it has no consciousness, scientists and admit that although at some stage of complication I can cause this. Work with such an application is less cruel than the use of experimental animals. What are the results of biocomputers produced in a cell? exists.
Source: Tech Cult

I am a professional journalist and content creator with extensive experience writing for news websites. I currently work as an author at Gadget Onus, where I specialize in covering hot news topics. My written pieces have been published on some of the biggest media outlets around the world, including The Guardian and BBC News.